NASDAQ:XOMA Shareholder Notice: Investigation over Potential Wrongdoing at XOMA Corporation

By , in PR PR California on .

San Diego, CA — 12/20/2017 — An investigation was announced for investors in shares of XOMA Corporation (NASDAQ:XOMA) was announced over potential breaches of fiduciary duties by certain directors at XOMA.

Investors who purchased shares of XOMA Corporation (NASDAQ:XOMA) have certain options and should contact the Shareholders Foundation at [email protected] or call 858-779-1554.

The investigation by a law firm concerns whether certain XOMA directors breached their fiduciary duties and caused damage to the company and its shareholders.

Emeryville, CA based XOMA Corporation is a development-stage biotechnology company that focuses on the discovery and development of monoclonal antibody-based therapeutic. XOMA Corporation reported that its annual Total Revenue declined from $55.45 million in 2015 to $5.56 million in 2016 and that its Net Loss increased from $20.61 million in 2015 to $53.53 million in 2016.

Shares of XOMA Corporation (NASDAQ:XOMA) closed on December 19, 2017 at $31.69 per share.

Those who purchased shares of XOMA Corporation (NASDAQ:XOMA), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
[email protected]

The following two tabs change content below.
Sarah Thompson

Sarah Thompson

Sarah is a financial reporter, focusing on technology, national security, and policing. Before joining Daily Telescope she worked as a staff writer at Fast Company and spent two years as a foreign correspondent in Turkey. Her work has been published in Al Jazeera America, The Nation, Vice News, Motherboard, and many other outlets.
%d bloggers like this: